Junyong Wu - Search Results

Year	Number of Results
2007	3
2009	2
2010	1
2011	1
2013	1
2014	3
2016	1
2017	1
2018	3
2019	9
2020	6
2021	13
2022	14
2023	6
2024	5

1

Artificial exosomes for translational nanomedicine.

Li YJ, Wu JY, Liu J, Xu W, Qiu X, Huang S, Hu XB, Xiang DX. Li YJ, et al. J Nanobiotechnology. 2021 Aug 12;19(1):242. doi: 10.1186/s12951-021-00986-2. J Nanobiotechnology. 2021. PMID: 34384440 Free PMC article. Review.

2

Bacterial outer membrane vesicles-based therapeutic platform eradicates triple-negative breast tumor by combinational photodynamic/chemo-/immunotherapy.

Li Y, Wu J, Qiu X, Dong S, He J, Liu J, Xu W, Huang S, Hu X, Xiang DX. Li Y, et al. Among authors: wu j. Bioact Mater. 2022 Jun 29;20:548-560. doi: 10.1016/j.bioactmat.2022.05.037. eCollection 2023 Feb. Bioact Mater. 2022. PMID: 35846843 Free PMC article.

3

Nonviral delivery systems for antisense oligonucleotide therapeutics.

Huang S, Hao XY, Li YJ, Wu JY, Xiang DX, Luo S. Huang S, et al. Biomater Res. 2022 Sep 30;26(1):49. doi: 10.1186/s40824-022-00292-4. Biomater Res. 2022. PMID: 36180936 Free PMC article. Review.

4

Knowledge mapping of syringomyelia from 2003 to 2022: A bibliometric analysis.

Wu J, Ji S, Niu P, Zhang B, Shao D, Li Y, Xie S, Jiang Z. Wu J, et al. J Clin Neurosci. 2023 Apr;110:63-70. doi: 10.1016/j.jocn.2023.01.004. Epub 2023 Feb 21. J Clin Neurosci. 2023. PMID: 36822071 Free article. Review.

5

Recent progress of macrophage vesicle-based drug delivery systems.

Xu WJ, Cai JX, Li YJ, Wu JY, Xiang D. Xu WJ, et al. Drug Deliv Transl Res. 2022 Oct;12(10):2287-2302. doi: 10.1007/s13346-021-01110-5. Epub 2022 Jan 4. Drug Deliv Transl Res. 2022. PMID: 34984664 Review.

6

Apoptotic bodies for advanced drug delivery and therapy.

Zhou M, Li YJ, Tang YC, Hao XY, Xu WJ, Xiang DX, Wu JY. Zhou M, et al. J Control Release. 2022 Nov;351:394-406. doi: 10.1016/j.jconrel.2022.09.045. Epub 2022 Sep 27. J Control Release. 2022. PMID: 36167267 Review.

7

Multiple delivery strategies of nanocarriers for myocardial ischemia-reperfusion injury: current strategies and future prospective.

Li S, Li F, Wang Y, Li W, Wu J, Hu X, Tang T, Liu X. Li S, et al. Among authors: wu j. Drug Deliv. 2024 Dec;31(1):2298514. doi: 10.1080/10717544.2023.2298514. Epub 2023 Dec 26. Drug Deliv. 2024. PMID: 38147501 Free PMC article. Review.

8

Emerging nanomedicine-based strategies for preventing metastasis of pancreatic cancer.

Li YJ, Wu JY, Wang JM, Xiang DX. Li YJ, et al. J Control Release. 2020 Apr 10;320:105-111. doi: 10.1016/j.jconrel.2020.01.041. Epub 2020 Jan 21. J Control Release. 2020. PMID: 31978441 Review.

9

Bacteria-based immunotherapy for cancer: a systematic review of preclinical studies.

Zhou M, Tang Y, Xu W, Hao X, Li Y, Huang S, Xiang D, Wu J. Zhou M, et al. Among authors: wu j. Front Immunol. 2023 Aug 3;14:1140463. doi: 10.3389/fimmu.2023.1140463. eCollection 2023. Front Immunol. 2023. PMID: 37600773 Free PMC article. Review.

10

Emerging strategies for labeling and tracking of extracellular vesicles.

Li YJ, Wu JY, Wang JM, Hu XB, Xiang DX. Li YJ, et al. J Control Release. 2020 Dec 10;328:141-159. doi: 10.1016/j.jconrel.2020.08.056. Epub 2020 Aug 31. J Control Release. 2020. PMID: 32882270 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

65 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year